The prognostic significance of p53, p27kip1, p21waf1, HER-2/neu, and ki67 proteins expression in gastric cancer:: A clinicopathological and lmmunohistochemical study of 121 Arab patients

被引:56
作者
Al-Moundhri, MS
Nirmala, V
Al-Hadabi, I
Al-Mawaly, K
Burney, I
Al-Nabhani, M
Thomas, V
Ganguly, SS
Grant, C
机构
[1] Sultan Qaboos Univ, Dept Med, Coll Med, Med Oncol Unit, Muscat, Oman
[2] Sultan Qaboos Univ, Coll Med, Dept Pathol, Muscat, Oman
[3] Sultan Qaboos Univ, Coll Med, Dept Epidemiol & Med Stat, Muscat, Oman
[4] Sultan Qaboos Univ, Coll Med, Dept Surg, Muscat, Oman
关键词
gastric cancer; stomach; prognosis; p53; p27(kip1); p21; HER-2/neu; Ki67; antigen; immunohistochemistry; Arabs;
D O I
10.1002/jso.20324
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The variability of prognosis within a pathological stage of gastric cancer (GC) at presentation, underscores the need for specific biological markers to identify subgroups of patients with aggressive course for intensive treatment. To our knowledge, this is the first study from an Arab population reporting on the relationship of p53, p27(kip1), p21(waf1), HER-2/neu, and Ki67 expression, and clinicopathological features and their prognostic significance. Methods: Formalin-fixed paraffin-embedded tumors were studied by immunohistochemistry, using monoclonal antibodies to p53, p27(kip1), p21(waf1), HER-2/neu, and Ki67. The results were correlated with clinicopathological features and survival. Results: M:F = 80:41; median age = 60 years; stage III and IV = 71%; and median follow-up = 34.4 months. Positive expression rates of p53, p27(kip1), p21(waf1), Ki67, and HER-2/neu were 54%, 40%, 8.3%, 70%, and 12% respectively. p53 expression correlated with age < 60 years (P = 0.03), tumor size > 5cm (P = 0.01), p27(kip1), and Ki67 expression (P = 0.0001), and HER-2/neu (P = 0.04). p21(waf1) correlated inversely with T-stage (P = 0.008) and Her-2/nett expression correlated with histological grade (P=0.04) and T-stage (P=0.008). Univariate analysis showed that p53 overexpression (P = 0.01), fungating and infiltrative macroscopic appearance (P = 0.02), size > 5 cm (P = 0.0001), lymph node metastasis (P = 0.0001), p T3 and T4 disease (P = 0.01), and overall stage III and IV (P = 0.0001) disease were adverse prognostic factors. Patients with tumor profiles p53 (-)/p27 (+) had better survival than those with p53 (+)/p27(kip1) (-)(P=0.02). On multivariate analysis by Cox regression model, the expression of p53 (P = 0.03) and lymph node involvement (P = 0.01) were significant adverse prognostic factors for overall survival. Conclusions: The expression of p53 in Arab patients with GC correlates with aggressive tumor characteristics and is an independent prognostic factor. The combined analysis of p53 and p27(kip1) is of added prognostic value.
引用
收藏
页码:243 / 252
页数:10
相关论文
共 72 条
  • [11] Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data
    Chou, I
    Norman, AR
    Cunningham, D
    Waters, JS
    Oates, J
    Ross, PJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2395 - 2403
  • [12] Gastric cancer: Establishing predictors of biologic behavior with use of population-based data
    Dicken, BJ
    Saunders, LD
    Jhangri, GS
    de Gara, C
    Cass, C
    Andrews, S
    Hamilton, SM
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (06) : 629 - 635
  • [13] Feakins RM, 2000, CANCER, V89, P1684, DOI 10.1002/1097-0142(20001015)89:8<1684::AID-CNCR6>3.0.CO
  • [14] 2-6
  • [15] TP53 and gastric carcinoma: A review
    Fenoglio-Preiser, CM
    Wang, J
    Stemmermann, GN
    Noffsinger, A
    [J]. HUMAN MUTATION, 2003, 21 (03) : 258 - 270
  • [16] High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers
    Fredersdorf, S
    Burns, J
    Milne, AM
    Packham, G
    Fallis, L
    Gillett, CE
    Royds, JA
    Peston, D
    Hall, PA
    Hanby, AM
    Barnes, DM
    Shousha, S
    OHare, MJ
    Lu, X
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 6380 - 6385
  • [17] Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer
    García, I
    del Casar, JM
    Corte, MD
    Allende, MT
    García-Muñiz, JL
    Vizoso, F
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2003, 18 (03) : 200 - 206
  • [18] Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer
    García, I
    Vizoso, F
    Martín, A
    Sanz, L
    Abdel-Lah, O
    Raigoso, P
    García-Muñiz, JL
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (03) : 234 - 241
  • [19] GERDES J, 1984, J IMMUNOL, V133, P1710
  • [20] Ghaderi Abbas, 2002, Pathology & Oncology Research, V8, P252